Clifford R. Jack

208.3k total citations · 37 hit papers
1.2k papers, 105.5k citations indexed

About

Clifford R. Jack is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Clifford R. Jack has authored 1.2k papers receiving a total of 105.5k indexed citations (citations by other indexed papers that have themselves been cited), including 631 papers in Psychiatry and Mental health, 473 papers in Physiology and 390 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Clifford R. Jack's work include Dementia and Cognitive Impairment Research (562 papers), Alzheimer's disease research and treatments (438 papers) and Advanced Neuroimaging Techniques and Applications (274 papers). Clifford R. Jack is often cited by papers focused on Dementia and Cognitive Impairment Research (562 papers), Alzheimer's disease research and treatments (438 papers) and Advanced Neuroimaging Techniques and Applications (274 papers). Clifford R. Jack collaborates with scholars based in United States, United Kingdom and Germany. Clifford R. Jack's co-authors include Ronald C. Petersen, David S. Knopman, Michael W. Weiner, Bradley F. Boeve, Prashanthi Vemuri, Matthew L. Senjem, Stephen D. Weigand, John Q. Trojanowski, William J. Jagust and Philip Scheltens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Clifford R. Jack

1.1k papers receiving 103.7k citations

Hit Papers

The diagnosis of dementia... 1989 2026 2001 2013 2011 2009 2013 2009 2010 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    2011 13.8k citations David S. Knopman, Clifford R. Jack et al. Alzheimer s & Dementia profile →
  2. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
    2009 3.4k citations Clifford R. Jack, David S. Knopman et al. profile →
  3. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
    2013 3.1k citations Clifford R. Jack, David S. Knopman et al. profile →
  4. Alzheimer's Disease Neuroimaging Initiative (ADNI)
    2009 1.6k citations Ronald C. Petersen, Paul Aisen et al. Neurology profile →
  5. The clinical use of structural MRI in Alzheimer disease
    2010 1.4k citations Clifford R. Jack et al. profile →
  6. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    2011 1.3k citations Clifford R. Jack, David S. Knopman et al. Alzheimer s & Dementia profile →
  7. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
    2016 1.2k citations Clifford R. Jack, William J. Jagust et al. Neurology profile →
  8. Mild Cognitive Impairment
    2009 1.1k citations Ronald C. Petersen, Rosebud O. Roberts et al. profile →
  9. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
    1999 1.1k citations Clifford R. Jack, Ronald Petersen et al. Neurology profile →
  10. The Alzheimer's Disease Neuroimaging Initiative
    2005 973 citations Michael W. Weiner, Ronald C. Petersen et al. profile →
  11. Automatic classification of MR scans in Alzheimer's disease
    2008 876 citations Clifford R. Jack et al. Brain profile →
  12. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
    1997 857 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  13. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
    2009 826 citations Clifford R. Jack, Val J. Lowe et al. Brain profile →
  14. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)
    2005 812 citations Michael W. Weiner, Ronald C. Petersen et al. Alzheimer s & Dementia profile →
  15. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    2024 776 citations Clifford R. Jack, William J. Jagust et al. Alzheimer s & Dementia profile →
  16. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
    2008 758 citations Clifford R. Jack, Val J. Lowe et al. Brain profile →
  17. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
    2013 698 citations Michael W. Weiner, Laurel Beckett et al. Alzheimer s & Dementia profile →
  18. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
    2000 691 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  19. Biomarker Modeling of Alzheimer’s Disease
    2013 687 citations Clifford R. Jack et al. profile →
  20. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
    1992 680 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  21. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
    2004 630 citations Clifford R. Jack, Jeffrey L. Gunter et al. Neurology profile →
  22. Defining imaging biomarker cut points for brain aging and Alzheimer's disease
    2016 583 citations Clifford R. Jack, Heather J. Wiste et al. Alzheimer s & Dementia profile →
  23. Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
    2010 558 citations Rema Raman, Clifford R. Jack et al. profile →
  24. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
    2011 554 citations Clifford R. Jack et al. Alzheimer s & Dementia profile →
  25. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults.
    1989 515 citations Clifford R. Jack et al. profile →
  26. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease
    2011 472 citations Clifford R. Jack, David S. Knopman et al. Annals of Neurology profile →
  27. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
    2018 413 citations Michelle M. Mielke, Prashanthi Vemuri et al. Alzheimer s & Dementia profile →
  28. Testing the Right Target and Right Drug at the Right Stage
    2011 411 citations Clifford R. Jack et al. profile →
  29. On the path to 2025: understanding the Alzheimer’s disease continuum
    2017 369 citations Clifford R. Jack et al. profile →
  30. Cascading network failure across the Alzheimer’s disease spectrum
    2015 359 citations David T. Jones, David S. Knopman et al. Brain profile →
  31. An autoradiographic evaluation of AV-1451 Tau PET in dementia
    2016 348 citations Val J. Lowe, Amanda M. Liesinger et al. profile →
  32. Drug development in Alzheimer’s disease: the path to 2025
    2016 346 citations Clifford R. Jack et al. profile →
  33. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
    2018 324 citations Michael W. Weiner, Laurel Beckett et al. Alzheimer s & Dementia profile →
  34. Longitudinal tau PET in ageing and Alzheimer’s disease
    2018 289 citations Clifford R. Jack, Heather J. Wiste et al. Brain profile →
  35. Performance of plasma phosphorylated tau 181 and 217 in the community
    2022 246 citations Michelle M. Mielke, Alicia Algeciras‐Schimnich et al. profile →
  36. Developing the ATX(N) classification for use across the Alzheimer disease continuum
    2021 205 citations Clifford R. Jack et al. profile →
  37. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
    2021 146 citations Michelle M. Mielke, Alicia Algeciras‐Schimnich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clifford R. Jack United States 152 53.7k 46.2k 29.9k 23.0k 16.1k 1.2k 105.5k
Ronald C. Petersen United States 157 61.2k 1.1× 51.4k 1.1× 29.4k 1.0× 14.3k 0.6× 18.2k 1.1× 1.1k 117.0k
Philip Scheltens Netherlands 137 43.9k 0.8× 36.4k 0.8× 29.8k 1.0× 16.3k 0.7× 18.2k 1.1× 1.2k 100.6k
David S. Knopman United States 142 47.4k 0.9× 40.8k 0.9× 23.0k 0.8× 11.4k 0.5× 14.8k 0.9× 1.0k 94.0k
John C. Morris United States 148 48.0k 0.9× 44.1k 1.0× 24.6k 0.8× 11.2k 0.5× 15.1k 0.9× 999 116.2k
Michael W. Weiner United States 132 30.7k 0.6× 27.8k 0.6× 19.9k 0.7× 16.8k 0.7× 10.4k 0.6× 890 71.2k
Bruce L. Miller United States 146 31.9k 0.6× 28.9k 0.6× 28.8k 1.0× 9.4k 0.4× 12.4k 0.8× 1.1k 90.5k
William J. Jagust United States 114 32.4k 0.6× 27.9k 0.6× 20.3k 0.7× 10.5k 0.5× 9.8k 0.6× 481 61.5k
Bradley T. Hyman United States 156 24.2k 0.5× 60.6k 1.3× 18.4k 0.6× 9.0k 0.4× 21.1k 1.3× 730 114.1k
Nick C. Fox United Kingdom 115 22.7k 0.4× 21.8k 0.5× 14.0k 0.5× 10.3k 0.4× 9.4k 0.6× 561 52.8k
Frederik Barkhof Netherlands 142 17.3k 0.3× 12.8k 0.3× 17.7k 0.6× 21.0k 0.9× 11.5k 0.7× 1.4k 88.8k

Countries citing papers authored by Clifford R. Jack

Since Specialization
Citations

This map shows the geographic impact of Clifford R. Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford R. Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford R. Jack more than expected).

Fields of papers citing papers by Clifford R. Jack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford R. Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford R. Jack. The network helps show where Clifford R. Jack may publish in the future.

Co-authorship network of co-authors of Clifford R. Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford R. Jack. A scholar is included among the top collaborators of Clifford R. Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford R. Jack. Clifford R. Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pink, Anna, Janina Krell‐Roesch, Jeremy A. Syrjanen, et al.. (2025). A Longitudinal Investigation of Prediabetes, Diabetes, HbA1c and Cognitive Trajectories Among Cognitively Unimpaired Individuals. Journal of the American Geriatrics Society. 74(2). 345–354.
2.
Aakre, Jeremiah A., Vijay K. Ramanan, Walter K. Kremers, et al.. (2025). Eligibility for donanemab trial in a population-based study of cognitive aging. The Journal of Prevention of Alzheimer s Disease. 12(4). 100088–100088. 2 indexed citations
3.
Walter, Alexa E., James J. Gugger, Thomas H. Mosley, et al.. (2025). Neuroimaging Correlates of Traumatic Brain Injury in an Older Community-Dwelling Population. Neurology. 104(8). e213506–e213506.
4.
Cogswell, Petrice M., Heather J. Wiste, Stephen D. Weigand, et al.. (2025). Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET. Alzheimer s & Dementia. 21(2). e14629–e14629. 2 indexed citations
5.
Carlos, Arenn F., Stephen D. Weigand, Nha Trang Thu Pham, et al.. (2025). White matter hyperintensities and TDP‐43 pathology in Alzheimer's disease. Alzheimer s & Dementia. 21(2). ealz14516–ealz14516. 1 indexed citations
6.
Cogswell, Petrice M., Trevor Andrews, Jerome Barakos, et al.. (2024). Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities. American Journal of Neuroradiology. 46(1). 24–32. 23 indexed citations
7.
Ismail, Zahinoor, Matthew L. Senjem, Clifford R. Jack, et al.. (2024). Associations of Mild Behavioral Impairment Domains with Brain Volumes: Cross-sectional Analysis of Atherosclerosis Risk in Community (ARIC) Study. Journal of the Academy of Consultation-Liaison Psychiatry. 66(1). 37–48.
8.
Kryza‐Lacombe, Maria, Michelle T. Kassel, Philip S. Insel, et al.. (2024). Anxiety in late-life depression: Associations with brain volume, amyloid beta, white matter lesions, cognition, and functional ability. International Psychogeriatrics. 36(11). 1009–1020. 3 indexed citations
9.
Warner, Nafisseh S., Andrew C. Hanson, Phillip J. Schulte, et al.. (2024). Prescription Opioids and Brain Structure in Community-Dwelling Older Adults. Mayo Clinic Proceedings. 99(5). 716–726. 3 indexed citations
10.
Corriveau‐Lecavalier, Nick, Jeyeon Lee, Ellen Dicks, et al.. (2023). Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer’s disease. Cerebral Cortex. 33(11). 7026–7043. 14 indexed citations
11.
Ramanan, Vijay K., Jonathan Graff‐Radford, Jeremy A. Syrjanen, et al.. (2023). Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. Neurology. 101(14). e1402–e1411. 45 indexed citations
12.
Carvalho, Diego Z., Stuart J. McCarter, Erik K. St. Louis, et al.. (2023). Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea. Neurology. 101(2). e125–e136. 13 indexed citations
13.
Carlos, Arenn F., Nirubol Tosakulwong, Stephen D. Weigand, et al.. (2022). Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies. Brain Communications. 4(3). fcac108–fcac108. 9 indexed citations
14.
Arani, Arvin, Christopher G. Schwarz, Heather J. Wiste, et al.. (2022). Left–Right Intensity Asymmetries Vary Depending on Scanner Model for FLAIR and T1 Weighted MRI Images. Journal of Magnetic Resonance Imaging. 56(3). 917–927. 2 indexed citations
15.
Petersen, Ronald C., Heather J. Wiste, Stephen D. Weigand, et al.. (2021). NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages. Annals of Neurology. 89(6). 1145–1156. 42 indexed citations
16.
Insel, Philip S., Meryl A. Butters, Ruth Morin, et al.. (2021). The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression. Journal of Alzheimer s Disease. 80(3). 991–1002. 14 indexed citations
17.
Power, Melinda C., Aozhou Wu, Robert I. Reid, et al.. (2019). Association of white matter microstructural integrity with cognition and dementia. Neurobiology of Aging. 83. 63–72. 39 indexed citations
18.
Risacher, Shannon L., Sungeun Kim, Kwangsik Nho, et al.. (2015). APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. eScholarship (California Digital Library). 4 indexed citations
19.
Vemuri, Prashanthi, Timothy G. Lesnick, Scott A. Przybelski, et al.. (2015). Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain. 138(3). 761–771. 210 indexed citations
20.
Murray, Melissa E., Scott A. Przybelski, Timothy G. Lesnick, et al.. (2014). Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy. Journal of Neuroscience. 34(49). 16247–16255. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald C. Petersen Breakdown of academic impact, for papers by Philip Scheltens Breakdown of academic impact, for papers by David S. Knopman Breakdown of academic impact, for papers by John C. Morris Breakdown of academic impact, for papers by Michael W. Weiner Breakdown of academic impact, for papers by Bruce L. Miller Breakdown of academic impact, for papers by William J. Jagust Breakdown of academic impact, for papers by Bradley T. Hyman Breakdown of academic impact, for papers by Nick C. Fox Breakdown of academic impact, for papers by Frederik Barkhof
Rankless by CCL
2026